Letters to the Editors Journal of Clinical Psychopharmacology Volume 39, Number 4, July/August 2019 2. Stallman HM, Kohler M, Wilson A, et al. BT into the glabellar region between May DISCUSSION Self-reported sleepwalking in Australian senior 2017 and October 2018. None of the pa- Guanfacine may suppress rapid eye move- secondary school students. Sleep Med. tients had hyperhidrosis. In 5 patients, ment sleep, modulate sleep architecture, 2016;25:1–3. previous and current pharmacologic and and can result in less sleepwalking. As a se- 3. De Cock VC. Sleepwalking. Curr Treat Options psychotherapeutic treatments had either lective α-adrenergic 2A agonist, it has the Neurol. 2016;18:1–9. been insufficient or were discontinued ability to regulate glutamatergic and catechol- secondary to side effects. All patients 4. Stallman HM, Kohler M. A systematic amine systems, both implicated in the neuro- review of treatments for sleepwalking: were maintained on their existing treat- chemistry of sleepwalking. Benzodiazepines 100 years of case studies. Sleep Hypnosis. ment regimen, and written consent was lessen sleepwalking through a sedative- 2016;1–22. obtained. SAnD symptoms were assessed hypnotic effect. Antidepressant medications 5. Fredriksson I, Jayaram-Lindström N, Wirf M, by the Leibowitz Social Anxiety Scale are thought to decrease sleepwalking owing et al. Evaluation of
Journal of Clinical Psychopharmacology – Wolters Kluwer Health
Published: Jan 1, 2019
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera